Equitec Proprietary Markets, LLC Xencor Inc Call Options Transaction History
Equitec Proprietary Markets, LLC
- $196 Million
- Q4 2024
Call Options
2 transactions
Others Institutions Holding XNCR
# of Institutions
199Shares Held
73.7MCall Options Held
1.7KPut Options Held
4.2K-
Black Rock Inc. New York, NY11.1MShares$147 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA8.98MShares$119 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.02MShares$106 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$81.1 Million6.6% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.04MShares$53.3 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $788M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...